Lataa...

Ranibizumab in diabetic macular edema

By 2050 the prevalence of diabetes will more than triple globally, dramatically increasing the societal and financial burden of this disease worldwide. As a consequence of this growth, it is anticipated that there will be a concurrent rise in the numbers of patients with diabetic macular edema (DME)...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Krispel, Claudia, Rodrigues, Murilo, Xin, Xiaoban, Sodhi, Akrit
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Baishideng Publishing Group Co., Limited 2013
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3874491/
https://ncbi.nlm.nih.gov/pubmed/24379922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4239/wjd.v4.i6.310
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!